USPTO serial 85313430
PROSTALEVE RX9
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- HERRERA-MARCUS, ROSELLE MORALDE
- Law office
- OFFICE OF TRADEMARK PROGRAM CONTROL
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROSTALEVE RX9?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements; Nutritional supplements | ABANDONED | Feb 13, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2011 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Oct 14, 2011 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 27, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 27, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 24, 2011 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Aug 18, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 2011 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| May 11, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2011 | NWAP | NEW APPLICATION ENTERED | — |